Intangible Assets and Goodwill

6 Months Ended

Jun. 30, 2015

Intangible Assets and Goodwill [Text Block]

Note 6 – Intangible Assets and Goodwill

Identifiable intangible assets

The Company’s identifiable intangible assets are associated with its acquisitions of HGP in 2012 and NLEX in 2014, as shown in the table below (dollars in thousands):

	Original	Remaining		Acquisition		Accumulated			Carrying Value
Amortized Intangible Assets	Life (years)	Life (years)		Cost		Amortization			June 30, 2015
Customer/Broker Network (HGP)	12	8.7	$	4,180	$	(1,161	)	$	3,019
Trade Name (HGP)	14	10.7		1,460		(348	)		1,112
Customer Relationships (NLEX)	7.6	6.6		834		(119	)		715
Non-Compete Agreement (NLEX)	2	0.9		71		(38	)		33
Website (NLEX)	5	3.9		48		(10	)		38
Total				6,593		(1,676	)		4,917

Unamortized Intangible Assets
Trade Name (NLEX)	N/A	N/A		2,437		—			2,437
Total			$	9,030	$	(1,676	)	$	7,354

Amortization expense during the first six months of 2015 and 2014 was $0.3 million and $0.2 million, respectively.

The estimated amortization expense as of June 30, 2015 during the next five fiscal years is shown below (in thousands):

Year		Amount
2015 (remainder of year from July 1, 2015 to December 31, 2015)		$303
2016		$587
2017		$572
2018		$572
2019		$566

Goodwill

The Company’s goodwill is related to its asset liquidation business, and is comprised of goodwill from three acquisitions, as shown in the table below (in thousands). There were no impairment losses or other charges to the carrying amount of goodwill during the six months ended June 30, 2015 and 2014.

Entity acquired	Acquisition date		Goodwill
Equity Partners	June 2011	$	573
HGP	February 2012		4,728
NLEX	June 2014		3,545
Total goodwill		$	8,846

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details